Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 24 (RPS26P24) is a processed pseudogene related to the RPS26 gene, which encodes a component of the small (40S) ribosomal subunit[5][7]. Pseudogenes are non-functional genomic DNA sequences similar to functional genes but typically lack protein-coding potential and do not produce functional proteins. RPS26P24 is not a protein-coding gene, nor is it established as a functional biological or therapeutic target[5][7]. There is no evidence linking RPS26P24 to disease, drug interactions, or biological pathways. It is one of many pseudogenes related to ribosomal protein S26 found dispersed throughout the human genome[5][7]. Note: - RPS26P24 is a pseudogene and not a functional gene or established molecular target; it should not be considered a therapeutic target. - No biological, pathological, or pharmacological functions are known for this pseudogene. - Requests or research relating to biological function or therapeutic targeting should refer to the functional gene, Ribosomal protein S26 (RPS26), not its pseudogenes[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 24 (RPS26P24).